Most health experts agree that early and aggressive treatment for COVID-19 helps to reduce the potential for long COVID symptoms and reduces the risk of severe disease. From the beginning, the pharmaceutical industry has sought to develop new and expensive antiviral drugs to treat the coronavirus responsible for COVID-19 with an aim at profits. The… Read More »
In a study sponsored by Yale University — and started before COVID-19 shots were rolled out — researchers tested different messages of how to best persuade people to get injected. Officially titled, “Persuasive Messages for COVID-19 Vaccine Uptake,”1 the researchers must have had some forethought that people would be wary of an experimental gene therapy,… Read More »
This article was previously published July 11, 2020, and has been updated with new information. In the video podcast above, Dr. Paul Saladino and science journalist and author Nina Teicholz — who is also executive director of The Nutrition Coalition — review the evidence against chicken, and why saturated fat really qualifies as a health… Read More »
Veklury has become routine treatment for severe COVID-19 patients in the U.S., spurring significant sales for Gilead Sciences. Experts have often debated data from the drug’s clinical trials, and now a small study adds points to the arguments voiced by skeptics. Both Veklury, also known as remdesivir, and hydroxychloroquine didn’t significantly clear the virus from hospitalized COVID-19… Read More »